Paulino M, Costa C, Neto M, Pedro E
Immunoallergology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal.
Immunoallergology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal.
Actas Dermosifiliogr (Engl Ed). 2021 Apr 24. doi: 10.1016/j.ad.2021.04.003.
Cold Urticaria (ColdU) is a type of chronic inducible urticaria (CIndU) where recurrent pruritic wheals and/or angioedema occur after exposure to cold stimulus. Although it usually only affects exposed areas, systemic reactions can occur in severe cases. In this study, we seek to characterize the ColdU cases within our Centre's population of patients.
Retrospective study based on clinical files of patients diagnosed with ColdU followed in an urticaria outpatient clinic in Portugal prior to October 2020.
We included 52 patients total (40 women) with median age of 35 years, 19 patients with symptom onset before 18 years-old. ColdU was classified as acquired in all patients. Cold provocation tests were negative in 9 patients and these were classified as atypical ColdU. No significant differences were found between those with pediatric or adult onset of disease. Most of the patients had a localized form of the disease (52%). Despite not being statistically significant, it was found that patient's temperature threshold, assessed with TempTest® 4.0, was higher and stimulation time was shorter in more severe groups. All patients were treated with non-sedating antihistamines (daily or on-demand), finding that those controlled with standard dosages had lower temperature thresholds than those needing higher dosages (p<0.01). One patient was under treatment with omalizumab.
ColdU is an heterogenous disease that can have life-threatening event consequences. Cold provocation tests and threshold assessment can be an important tool in the management treatment and in identifying severity groups.
寒冷性荨麻疹(ColdU)是一种慢性诱导性荨麻疹(CIndU),在接触冷刺激后会反复出现瘙痒性风团和/或血管性水肿。虽然它通常只影响暴露部位,但严重时可发生全身反应。在本研究中,我们试图对本中心患者群体中的寒冷性荨麻疹病例进行特征描述。
基于2020年10月之前在葡萄牙一家荨麻疹门诊随访的被诊断为寒冷性荨麻疹患者的临床档案进行回顾性研究。
我们共纳入52例患者(40名女性),中位年龄为35岁,19例患者症状在18岁之前出现。所有患者的寒冷性荨麻疹均被分类为获得性。9例患者的冷激发试验为阴性,这些患者被分类为非典型寒冷性荨麻疹。疾病在儿童期或成人期发病的患者之间未发现显著差异。大多数患者的疾病为局限性(52%)。尽管无统计学意义,但发现使用TempTest® 4.0评估时,病情较重组患者的温度阈值较高,刺激时间较短。所有患者均接受非镇静性抗组胺药治疗(每日或按需),发现用标准剂量控制的患者比需要更高剂量的患者温度阈值更低(p<0.01)。1例患者正在接受奥马珠单抗治疗。
寒冷性荨麻疹是一种异质性疾病,可能会导致危及生命的后果。冷激发试验和阈值评估可能是管理治疗和识别严重程度组别的重要工具。